MADR2 gene

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMADR2 gene
Drug Alias Namecolon cancer gene therapy (Hosp Sick Children)
ClassificationBiologics
Mechanisms of ActionMothers against decapentaplegic homolog 2 modulators
TargetsMothers against decapentaplegic homolog 2
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hospital For Sick Children
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Hospital For Sick Children
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A